| | | | | |
AARD Aardvark Therapeutics, Inc. Common Stock | $5.3150 | -1.21 % | $126.71M | $250.27K | |
FXAC FortuneX Acquisition Corporation Ordinary shares | $10.0600 | +0.10 % | $126.57M | $1.05K | |
INVZ Innoviz Technologies Ltd. Ordinary shares | $0.34490 | -0.09 % | $126.53M | $3.24M | |
SJT San Juan Basin Royalty Trust UBI | $2.9600 | +0.00 % | $126.30M | $110.45K | |
SANG Sangoma Technologies Corporation Common Shares | $3.6950 | -0.40 % | $126.12M | $22.27K | |
CBUS Cibus, Inc. Class A Common Stock | $1.5900 | +0.00 % | $126.10M | $71.78K | |
RDZN Roadzen, Inc. Ordinary Shares | $1.3000 | +0.78 % | $126.04M | $258.43K | |
NYXH Nyxoah SA Ordinary Shares | $1.6100 | -0.62 % | $126.03M | $939.02K | |
MXCT MaxCyte, Inc. Common Stock | $1.2950 | +1.17 % | $125.91M | $324.93K | |
| $19.5700 | -1.16 % | $125.78M | $1.66K | |
GGZ The Gabelli Global Small and Mid Cap Value Trust | $16.2500 | +0.00 % | $125.64M | $5.29K | |
NMI Nuveen Municipal Income | $10.4300 | +0.00 % | $125.61M | $15.96K | |
| $1.1500 | +0.00 % | $125.56M | $208.08K | |
BMEA Biomea Fusion, Inc. Common Stock | $2.0300 | +0.00 % | $125.39M | $3.25M | |
LIXT Lixte Biotechnology Holdings, Inc. Common Stock | $7.2850 | +1.04 % | $125.35M | $610.69K | |
